The FTO risk variant rs9939609 is associated with a modest increase in obesity risk (GWAS, OR ~1.3–2.1). During menopause (Wechseljahre), hormonal changes often lead to weight gain and altered fat distribution. While FTO may amplify this tendency, the effect is small and lifestyle factors (diet, exercise) are far more influential. Evidence for a direct FTO–menopause interaction is weak; most GWAS show the FTO effect is consistent across life stages. Caveat: a single SNP is not deterministic. Weight management should consider genetics, hormones, and lifestyle holistically. Evidence: gwas. Sources: deep-ragdb-03-gwas-snp-rs9939609.md; deep-ragdb-11-stress-neuro-gwas-snp-rs6265.md (related BDNF weight association).
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-99cea5d03a5ae694ccf45108